Results of immunotherapy for patients with unexplained primary recurrent abortions - Prospective non-randomized cohort study

American Journal of Reproductive Immunology

Volumn 58, Issue 6, 2007, Pages 530-536

  Nonaka, Taro ^a   Takakuwa, Koichi ^a   Ooki, Izumi ^a   Akashi, Mami ^a   Yokoo, Tomokazu ^a   Kikuchi, Akira ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Immunotherapy; MLR blocking antibodies; Primary habitual abortion; Prospective cohort study

Indexed keywords

ANTIBODY DETECTION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIXED LYMPHOCYTE REACTION; PATERNAL LYMPHOCYTE IMMUNOTHERAPY; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RECURRENT ABORTION;

ABORTION, HABITUAL; ADOPTIVE TRANSFER; ADULT; COHORT STUDIES; FATHERS; FEMALE; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 36049007241     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00536.x     Document Type: Article

References (29)

1. Beer AE, Quebbeman JR, Ayers JWT, Haines RF: Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 1981; 141:987-999.
2. Taylor C, Faulk WP: Prevention of recurrent abortion with leucocyte transfusions. Lancet 1981; ii:68-70.
3. Takakuwa K, Kanazawa K, Takeuchi S: Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: The role in successful pregnancies. Am J Reprod Immunol Microbiol 1986; 10:1-9.
4. Takakuwa K, Goto S, Hasegawa I, Ueda H, Kanazawa K, Takeuchi S, Tanaka K: Result of immunotherapy on patients with unexplained recurrent abortion: A beneficial treatment for patients with negative blocking antibodies. Am J Reprod Immunol 1990; 23:37-41.
5. Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide collaborative observational study and metaanalysis on allogeneic leucocyte immunotherapy for recurrent spontaneous abortions. Am J Reprod Immunol 1994; 32:55-72.
6. Adachi H, Takakuwa K, Mitsui T, Ishii K, Tamura M, Tanaka K: Results of immunotherapy for patients with unexplained secondary recurrent abortions. Clin Immunol 2003; 106:175-180.
7. Kling C, Steinmann J, Flesch B, Westphal E, Kabelitz D: Transfusion-related risks of intradermal allogeneic lymphocyte immunotherapy: Single cases in a large cohort and review of the literature. Am J Reprod Immunol 2006; 56:157-171.
8. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1985; I:941-943.
9. Gatenby PA, Cameron K, Simes RH, Adelstein S, Bennett MJ, Jansen RPS, Shearman RP, Stewart GJ, Whittle M, Doran TJ: Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: Results of a controlled trial. Am J Reprod Immunol 1993; 29:88-94.
10. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunization in prevention of recurrent miscarriages: A randomised trial. Lancet 1999; 354:365-369.
11. Pandey MK, Agrawal S: Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 2004; 4:289-298.
12. Takakuwa K, Higashino M, Yasuda M, Ishii S, Ueda H, Asano K, Kazama Y, Tanaka K: Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy. Am J Reprod Immunol 1993; 29:39-44.
13. Ogawa Y, Iwamura T, Kuriya N, Nishida H, Takeuchi H, Takada M, Itabashi K, Imura S, Isobe K: Birth size standards by gestational age for Japanese neonates. Acta Neonat Jpn 1998; 34:624-632.
14. Pandey MK, Rani R, Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95-108.
15. Ramhorst R, Agriello E, Zittermann S, Pando M, Larriba J, Irigoyen M, Cortelezzi M, Auge L, Lombardi E, Etchepareborda JJ, Cotreras Ortiz C, Fainboim L: Is the paternal mononuclear cells' immunization a successful treatment for recurrent spontaneous abortion? Am J Reprod Immunol 2000; 44:129-135.
16. Park MI, Edwin SS, Scott JR, Branch DW: Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results. Clin Exp Immunol 1990; 82:363-368.
17. Porter TF, LaCoursiere Y, Scott JR: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006; CD000112.
18. Clark DA, Coulam CB, Daya S, Chaouat G: Unexplained sporadic and recurrent miscarriage in the new millennium: A critical analysis of immune mechanisms and treatment. Hum Reprod Update 2001; 7:501-511.
19. Clark DA, Yu G, Levy GA, Gorczynski RM: Procoagulants in fetus rejection: The role of the OX-2 (CD200) tolerance signal. Semin Immunol 2001; 13:255-263.
20. Clark DA: Shall we properly re-examine the status of allogeneic lymphocyte therapy for recurrent early pregnancy failure? Am J Reprod Immunol 2004; 51:7-15.
21. Wegmann TG: PlacentaM immunotrophism: maternal T cell enhance placental growth and function. Am J Reprod Immunol Microbiol 1987; 15:67-69.
22. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
23. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
24. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
25. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
26. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J: A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53:241-256.
27. Trowsdale J, Betz AM: Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006; 7:241-246.
28. Hayakawa S, Karasaki-Suzuki M, Ito T, Ishii M, Kanaeda T, Nagai N, Takahashi-Yamamoto N, Tochigi M, Chishima F, Fujii TK, Oyama J, Kitanaka S, Sato K: Effects of paternal lymphocyte immunization on peripheral Th1/ Th2 balance and TCR V beta and V gamma repertoire usage of patients with recurrent spontaneous abortions. Am J Reprod Immunol 2000; 43:107-115.
29. Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M, Tanaka K: Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 2006; 85:1452-1458.